{"id":10195,"date":"2026-06-20T16:47:44","date_gmt":"2026-06-20T21:47:44","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=10195"},"modified":"2026-06-20T16:54:22","modified_gmt":"2026-06-20T21:54:22","slug":"nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ar\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/","title":{"rendered":"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"10195\" class=\"elementor elementor-10195\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6d5ad04f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6d5ad04f\" data-element_type=\"section\" data-e-type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5bf9bdef\" data-id=\"5bf9bdef\" data-element_type=\"column\" data-e-type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e3a8c93 elementor-widget elementor-widget-text-editor\" data-id=\"e3a8c93\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b><span data-contrast=\"none\">SAN DIEGO, CA,\u00a0 June 22, 2026<\/span><\/b><span data-contrast=\"none\">\u00a0\u2014\u00a0Nanoscope\u00a0Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced that\u00a0Co-founder and\u00a0CEO Sulagna Bhattacharya will participate in\u00a0executive leadership\u00a0panel discussion hosted by Women\u00a0In\u00a0Bio\u00a0during the 2026 BIO International Convention.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559738&quot;:240,&quot;335559739&quot;:160}\">\u00a0<\/span><\/p><p><span data-contrast=\"none\">Members of the\u00a0Nanoscope\u00a0leadership team will also\u00a0attend the\u00a0BIO\u00a0International Convention\u00a0and\u00a0be\u00a0available\u00a0for meeting\u00a0at the San Diego Convention Center\u00a0during\u00a0June 22<\/span><span data-contrast=\"none\">\u0627\u062e\u062a\u0635\u0627\u0631 \u0627\u0644\u062b\u0627\u0646\u064a<\/span><span data-contrast=\"none\">-25<\/span><span data-contrast=\"none\">\u0630<\/span><span data-contrast=\"none\">.\u00a0\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559738&quot;:240,&quot;335559739&quot;:160}\">\u00a0<\/span><\/p><p><b><span data-contrast=\"none\">Panel\u00a0DETAILS<\/span><\/b><span data-ccp-props=\"{&quot;335559738&quot;:200,&quot;335559739&quot;:120}\">\u00a0<\/span><\/p><p><b><span data-contrast=\"none\">Panel\u00a0Session Title:\u00a0<\/span><\/b><span data-contrast=\"none\">Building Resilient Organizations in an Era of Uncertainty<\/span><span data-ccp-props=\"{&quot;335559739&quot;:80}\"> <br \/><\/span><b><span data-contrast=\"none\">\u062a\u0627\u0631\u064a\u062e:\u00a0<\/span><\/b><span data-contrast=\"none\">Tuesday, June 23, 2026<\/span><span data-ccp-props=\"{&quot;335559739&quot;:80}\">\u00a0<br \/><\/span><b><span data-contrast=\"none\">\u0648\u0642\u062a:\u00a0\u00a0<\/span><\/b><span data-contrast=\"none\">5:30 \u2013 7:30 p.m. PT<\/span><span data-ccp-props=\"{&quot;335559739&quot;:80}\">\u00a0<br \/><\/span><b><span data-contrast=\"none\">\u0645\u0648\u0642\u0639:\u00a0\u00a0<\/span><\/b><span data-contrast=\"none\">GENESIS Labs, 1155 Island Avenue, San Diego, CA<\/span><span data-ccp-props=\"{&quot;335559739&quot;:80}\">\u00a0<br \/><\/span><b><span data-contrast=\"none\">Audience:\u00a0<\/span><\/b><span data-contrast=\"none\">Executive Leadership \u2013 Public Event<\/span><span data-ccp-props=\"{&quot;335559739&quot;:80}\">\u00a0<\/span><\/p><p><b><span data-contrast=\"none\">PANEL PARTICIPANTS:<\/span><\/b><\/p><p><b><span data-contrast=\"none\">SPEAKERS:<br \/>Sulagna Bhattacharya,<\/span><\/b><span data-contrast=\"none\">\u00a0CEO,\u00a0Nanoscope\u00a0Therapeutics<\/span><span data-ccp-props=\"{&quot;335559739&quot;:200}\">\u00a0<br \/><\/span><b><span data-contrast=\"none\">Tamar Grossman,<\/span><\/b><span data-contrast=\"none\">\u00a0CEO, La Jolla Labs<\/span><span data-ccp-props=\"{&quot;335559739&quot;:80}\"><br \/><strong>Erin O\u2019Donnell<\/strong>, Partner at PwC<\/span><\/p><p><strong>MODERATOR:<br \/>Katherine Andersen \u2013 <\/strong>Head of Life Science & Healthcare, HSBC Innovation Banking<strong><br \/><\/strong><\/p><p><span data-contrast=\"none\">The\u00a0panel,\u00a0part\u00a0of\u00a0Women in Bio\u2019s (WIB) Annual Plenary during the 2026 BIO International Convention, will\u00a0bring together\u00a0female CEOs and senior leaders who have navigated complexity across science,\u00a0capital\u00a0and organizational transformation.\u00a0\u00a0Designed for executive leadership audiences, the panel will address the most pressing challenges facing leaders today: making high-stakes decisions with incomplete information,\u00a0maintaining\u00a0team alignment and culture under pressure, and building organizations that can withstand sustained change.\u00a0\u00a0The discussion will focus on leading through ambiguity, balancing transparency with confidence, managing risk, sustaining culture under pressure, and helping teams adapt\u00a0to unpredictable environments.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:160}\">\u00a0<\/span><\/p><p><i><span data-contrast=\"none\">\u201cI am honored to join this distinguished group of leaders at BIO 2026,\u201d\u00a0<\/span><\/i><span data-contrast=\"none\">said Sulagna Bhattacharya, Co-founder and CEO of\u00a0Nanoscope.<\/span><i><span data-contrast=\"none\">\u00a0\u201cBuilding a resilient organization is\u00a0inseparable from our mission to restore vision\u00a0for patients living\u00a0with\u00a0retinal degeneration.\u00a0\u00a0We must lead with clarity and purpose \u2014 especially when the path forward is uncertain.\u201d<\/span><\/i><span data-contrast=\"none\">\u00a0<\/span><span data-ccp-props=\"{&quot;335559739&quot;:80}\">\u00a0<\/span><\/p><p><span data-contrast=\"none\">Designed for executive leaders, the panel will offer practical perspectives and firsthand experiences for building organizations capable of not only withstanding\u00a0uncertainty but\u00a0emerging\u00a0from it stronger and better positioned to fulfill their missions.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p><p><b><span data-contrast=\"none\">ABOUT NANOSCOPE THERAPEUTICS<\/span><\/b><span data-ccp-props=\"{&quot;335559738&quot;:200,&quot;335559739&quot;:80}\">\u00a0<\/span><\/p><p><span data-contrast=\"none\">Nanoscope\u00a0Therapeutics is developing disease-agnostic, vision-restoring optogenetic therapy for millions of patients blinded by retinal degenerative diseases. Following positive results from the RESTORE Phase 2b\/3 multicenter, randomized, double-masked, sham-controlled clinical trial for RP (<\/span><a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/\/clinicaltrials.gov\/study\/NCT04945772___.YXAzOm5hbm9zY29wZXRoZXJhcGV1dGljczpjOm9mZmljZTM2NV9lbWFpbHNfYXR0YWNobWVudDo3NjVjZmIyNjAwMWM2ZjY3M2I2MzhkNzhmYzcxODZlZDo3OmIxNmI6MDc4M2IzYjZlNTZhNTU0NzE3OWM5MDFhMDE5NGE1ZWRhMDA0YTAyMjI1ODdkYWQyOTlhMmYzYjZlN2M4YmI5MzpwOlQ6Rg\"><span data-contrast=\"none\">NCT04945772<\/span><\/a><span data-contrast=\"none\">), a rolling BLA submission to the FDA has been\u00a0initiated. If approved, MCO-010 has the potential to be the standard of care for RP patients, administered as a one-time, in-office injection without the need for genetic testing. The company has also shown promising results in the STARLIGHT Phase 2 clinical trial of MCO-010 in SD (<\/span><a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/\/clinicaltrials.gov\/study\/NCT05417126___.YXAzOm5hbm9zY29wZXRoZXJhcGV1dGljczpjOm9mZmljZTM2NV9lbWFpbHNfYXR0YWNobWVudDo3NjVjZmIyNjAwMWM2ZjY3M2I2MzhkNzhmYzcxODZlZDo3OjdlMzA6NmZhZWRmNzBjMTY4YjRmMTc4MDU2OWZjMWM2NzYzOWY3YzQxMDlkZmZlMTEzMjk1YjlhMjU0MzNiYTZkYzI4NjpwOlQ6Rg\"><span data-contrast=\"none\">NCT05417126<\/span><\/a><span data-contrast=\"none\">) and plans to\u00a0initiate\u00a0a\u00a0<\/span><a href=\"https:\/\/protect.checkpoint.com\/v2\/r01\/___https:\/\/nanostherapeutics.com\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/___.YXAzOm5hbm9zY29wZXRoZXJhcGV1dGljczpjOm9mZmljZTM2NV9lbWFpbHNfYXR0YWNobWVudDo3NjVjZmIyNjAwMWM2ZjY3M2I2MzhkNzhmYzcxODZlZDo3OmFmYmQ6YmU5Y2JjNTYyMTBiYmM3NzIyMTg4NDNkNmNmYjU3YTE4YzhjNDExMzdhODE0ZDE2NjgyMzlkZTU3ZmMzNTQ2YzpwOlQ6Rg\"><span data-contrast=\"none\">\u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0644\u062b\u0629 \u0645\u0646 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u062a\u0633\u062c\u064a\u0644\u064a\u0629<\/span><\/a><span data-contrast=\"none\">\u00a0in 2026. MCO-010 has received FDA Fast Track and Orphan Drug designations for both RP and SD, along with RMAT\u00a0designation\u00a0for SD, and EMA Orphan designations to cover non-syndromic and syndromic rod- and cone-dominant dystrophies, as well as macular dystrophies.\u00a0MCO-010 has received Sakigake and orphan designations for inherited retinal dystrophies (IRDs) in Japan and an orphan designation for IRDs in Saudi Arabia.\u00a0A Phase 2 program for MCO in GA\u00a0is expected\u00a0to start in 2026. Other IND-ready programs include Leber congenital amaurosis (LCA).<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:80}\">\u00a0<\/span><\/p><p><span data-ccp-props=\"{&quot;335559739&quot;:160}\">\u00a0<\/span><\/p><p><b><span data-contrast=\"none\">MEDIA CONTACT<\/span><\/b><span data-ccp-props=\"{&quot;335559739&quot;:80}\">\u00a0<br \/><\/span><b><span data-contrast=\"none\">Nanoscope\u00a0Therapeutics, Inc.<\/span><\/b><span data-ccp-props=\"{&quot;335559739&quot;:60}\">\u00a0<br \/><\/span><span data-contrast=\"none\">+1 (817) 857-1186<\/span><span data-ccp-props=\"{&quot;335559739&quot;:60}\">\u00a0<br \/><\/span><a href=\"mailto:PR@nanostherapeutics.com\"><span data-contrast=\"none\">PR@nanostherapeutics.com<\/span><\/a><span data-ccp-props=\"{&quot;335559739&quot;:60}\">\u00a0<\/span><\/p><p><span data-ccp-props=\"{&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, CA,\u00a0 June 22, 2026\u00a0\u2014\u00a0Nanoscope\u00a0Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced that\u00a0Co-founder and\u00a0CEO Sulagna Bhattacharya will participate in\u00a0executive leadership\u00a0panel discussion hosted by Women\u00a0In\u00a0Bio\u00a0during the 2026 BIO International Convention.\u00a0 Members of the\u00a0Nanoscope\u00a0leadership team will also\u00a0attend [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":10196,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-10195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ar\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ar\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-20T21:47:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-20T21:54:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Wilson PJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Wilson PJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u062f\u0642\u0627\u0626\u0642\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/\"},\"author\":{\"name\":\"Wilson PJ\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\"},\"headline\":\"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel\",\"datePublished\":\"2026-06-20T21:47:44+00:00\",\"dateModified\":\"2026-06-20T21:54:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/\"},\"wordCount\":537,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_BIO2026_REV.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/\",\"name\":\"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_BIO2026_REV.jpg\",\"datePublished\":\"2026-06-20T21:47:44+00:00\",\"dateModified\":\"2026-06-20T21:54:22+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_BIO2026_REV.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_BIO2026_REV.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/06\\\/20\\\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\",\"name\":\"Wilson PJ\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel - Nanoscope Therapeutics","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ar\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/","og_locale":"ar_AR","og_type":"article","og_title":"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ar\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2026-06-20T21:47:44+00:00","article_modified_time":"2026-06-20T21:54:22+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Wilson PJ","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Wilson PJ","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"3 \u062f\u0642\u0627\u0626\u0642"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/"},"author":{"name":"Wilson PJ","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d"},"headline":"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel","datePublished":"2026-06-20T21:47:44+00:00","dateModified":"2026-06-20T21:54:22+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/"},"wordCount":537,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_BIO2026_REV.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/","url":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/","name":"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel - Nanoscope Therapeutics","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_BIO2026_REV.jpg","datePublished":"2026-06-20T21:47:44+00:00","dateModified":"2026-06-20T21:54:22+00:00","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_BIO2026_REV.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_BIO2026_REV.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2026\/06\/20\/nanoscope-therapeutics-to-participate-in-bio-international-convention-2026-and-women-in-bio-panel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to Participate in BIO International Convention 2026 and Women In Bio Panel"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628","description":"\u0625\u0639\u0627\u062f\u0629 \u0646\u0648\u0631 \u0627\u0644\u0623\u0645\u0644","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d","name":"\u0648\u064a\u0644\u0633\u0648\u0646 \u0628\u064a \u062c\u064a\u0647"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/10195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/comments?post=10195"}],"version-history":[{"count":4,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/10195\/revisions"}],"predecessor-version":[{"id":10200,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/10195\/revisions\/10200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media\/10196"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media?parent=10195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/categories?post=10195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/tags?post=10195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}